Sectors
DMRA
Damora Therapeutics, Inc.
28.18
2 x 20.49
1 x 28.19
bid
ask
-
0.82
2.83%
2 @ 04:41 PM
28.56 +0.38 (1.35%)
| Ytd | 22.47% | |
| 1y | 786.16% |
26.52
day range
28.93
2.45
52 week range
38.33
| Open | 28.93 | Prev Close | 29.00 | Low | 26.52 | High | 28.93 | Mkt Cap | 1.74B |
| Vol | 497.02K | Avg Vol | 565.97K | EPS | -0.26 | P/E | N/A | Forward P/E | -13.15 |
| Beta | 1.48 | Short Ratio | 11.63 | Inst. Own | 105.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 29.04 | 200-d Avg | 25.96 | 1yr Est | 44.67 |
| Income Statement | |||
| Operating Expenses | 34.99M | ||
| Research and Development Expense | 25.54M | ||
| Selling, General and Administrative Expense | 9.45M | ||
| Operating Income | -34.99M | ||
| Income Tax Expense | 255.00K | ||
| Net Income | -31.17M | ||
| Net Income Common Stock | -31.17M | ||
| Net Income Common Stock (USD) | -31.17M | ||
| Consolidated Income | -31.17M | ||
| Earnings per Basic Share | -0.39 | ||
| Earnings per Basic Share (USD) | -0.39 | ||
| Earnings per Diluted Share | -0.39 | ||
| Earning Before Interest & Taxes (EBIT) | -30.92M | ||
| Earning Before Interest & Taxes (USD) | -30.92M | ||
| Weighted Average Shares | 61.12M | ||
| Weighted Average Shares Diluted | 61.12M | ||
| Balance Sheet | |||
| Cash and Equivalents | 540.52M | ||
| Cash and Equivalents (USD) | 540.52M | ||
| Current Assets | 543.59M | ||
| Total Assets | 543.64M | ||
| Current Liabilities | 27.55M | ||
| Total Liabilities | 27.58M | ||
| Accumulated Retained Earnings (Deficit) | -546.32M | ||
| Accumulated Other Comprehensive Income | 732.00K | ||
| Shareholders Equity | 516.06M | ||
| Shareholders Equity (USD) | 516.06M | ||
| Assets Non-Current | 48.00K | ||
| Liabilities Non-Current | 27.00K | ||
| Trade and Non-Trade Payables | 3.48M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 11.00K | ||
| Net Cash Flow from Financing | 29.51M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.64M | ||
| Issuance (Purchase) of Equity Shares | 50.95M | ||
| Net Cash Flow from Operations | -21.87M | ||
| Effect of Exchange Rate Changes on Cash | -22.00K | ||
| Share Based Compensation | 6.14M | ||